We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics’ JETREA® Receives Positive Common Drug Review in Canada

News   Dec 30, 2013

 
ThromboGenics’ JETREA® Receives Positive Common Drug Review in Canada
 
 
 

RELATED ARTICLES

Curing Drug-Resistant Infections Without Antibiotics

News

Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.

READ MORE

Treatment Eliminates Nicotine Addiction in Preclinical Tests

News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

READ MORE

A Way to Make Drug-like Molecules with Ultra-high Purity

News

Purdue University researchers, including chemistry professor and Nobel Prize winner Ei-ichi Negishi, have developed technology to create a new chemical process to synthesize drug-like molecules with ultra-high purity.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE